Inventor · disambiguated record
Cyril B. Dousson
Also filed as: DOUSSON CYRIL · DOUSSON CYRIL B
26 granted patents·14 pending applications·450 citations·filing 2005–2021
96Inventor score
Files withIDENIX PHARMACEUTICALS INC16IDENIX PHARMACEUTICALS LLC11BOGEN STEPHANE3DOUSSON CYRIL2MERCK SHARP & DOHME2
Top patents by PatentIndex Score
40 records- 0198US8507460B2Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Aug 13, 2013·67 cites·20 claims
- 0296US9109001B23′,5′-cyclic phosphoramidate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·60 cites·28 claims
- 0395US8951985B2Compounds and pharmaceutical compositions for the treatment of viral infectionsSURLERAUX DOMINIQUE·Filed 2012·Granted Feb 10, 2015·47 cites·22 claims
- 0495US8362068B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·66 cites·53 claims
- 0594US9296778B23′,5′-cyclic phosphate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·37 cites·21 claims
- 0694US7932240B2Phosphadiazine HCV polymerase inhibitors IVIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Apr 26, 2011·39 cites·61 claims
- 0793US9339541B2Thiophosphate nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·36 cites·20 claims
- 0890US8193372B2Phosphothiophene and phosphothiazole HCV polymerase inhibitorsDOUSSON CYRIL·Filed 2010·Granted Jun 5, 2012·37 cites·29 claims
- 0990US7534809B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2005·Granted May 19, 2009·16 cites·82 claims
- 1085US10449208B2Antiviral prodrugs of tenofovirMERCK SHARP & DOHME·Filed 2017·Granted Oct 22, 2019·3 cites·18 claims
- 1185US9403863B2Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infectionsSURLERAUX DOMINIQUE·Filed 2012·Granted Aug 2, 2016·13 cites·14 claims
- 1284US11730748B2Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseasesMSD INT GMBH·Filed 2020·Granted Aug 22, 2023·1 cites·11 claims
- 1384US9187496B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·8 cites·45 claims
- 1483US10815264B2Nucleotides for the treatment of cancerIDENIX PHARMACEUTICALS LLC·Filed 2016·Granted Oct 27, 2020·2 cites·10 claims
- 1580US10202411B23′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Feb 12, 2019·3 cites·29 claims
- 1679US10030044B2Nucleotides for the treatment of liver cancerIDENIX PHARMACEUTICALS LLC·Filed 2014·Granted Jul 24, 2018·4 cites·46 claims
- 1779US7960428B2Enantiomerically pure phosphoindoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Jun 14, 2011·3 cites·42 claims
- 1878US10899788B2Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Granted Jan 26, 2021·3 cites·17 claims
- 1976US8044091B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·2 cites·25 claims
- 2073US10683321B24′-or nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2014·Granted Jun 16, 2020·2 cites·17 claims
- 2171US10766917B2Nucleotides for the treatment of cancerIDENIX PHARMACEUTICALS LLC·Filed 2016·Granted Sep 8, 2020·1 cites·7 claims
- 2264US2022040214A1Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2364US2015037282A1D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver diseaseIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2456US10513534B22′-chloro nucleoside analogs for HCV infectionIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Dec 24, 2019·0 cites·60 claims
- 2556US10238680B2D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Mar 26, 2019·0 cites·21 claims
- 2655US2017198005A12'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infectionIDENIX PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2754US2014271547A1Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcvIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2854US2016229866A1Hepatitis c virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2952US10231986B2Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCVCENTRE NAT RECH SCIENT·Filed 2015·Granted Mar 19, 2019·0 cites·31 claims
- 3052US2019365788A1Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseasesIDENIX PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 3152US2014140952A1D-Alanine Ester of Sp-Nucleoside AnalogIDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3250US8486991B2Enantiomerically pure phosphoindoles as HIV inhibitorsSTORER RICHARD·Filed 2011·Granted Jul 16, 2013·0 cites·22 claims
- 3347US2020179428A1Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Application pending·0 cites
- 3447US2016002281A1D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 3545US10005779B21′,4′-thio nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2014·Granted Jun 26, 2018·0 cites·24 claims
- 3644US2014140951A1D-Alanine Ester of Rp-Nucleoside AnalogIDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3742US2016083413A12'-chloro nucleoside analogs for hcv infectionIDENIX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3840US2019192548A1Use of cyclic phosphate substituted nucleoside derivativesfor the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Application pending·0 cites
- 3938US2012252721A1Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitorDOUSSON CYRIL B·Filed 2012·Application pending·0 cites
- 4031US2017101431A1Nucleoside derivatives for the treatment of cancerDOUSSON CYRIL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cyril B. Dousson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →